PMVP Insider Trading
Insider Ownership Percentage: 7.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $15,163.50
PMV Pharmaceuticals Insider Trading History Chart
This chart shows the insider buying and selling history at PMV Pharmaceuticals by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
PMV Pharmaceuticals Share Price & Price History
Current Price: $1.24
Price Change: ▼ Price Decrease of -0.02 (-1.59%)
As of 03/13/2025 05:00 PM ET
PMV Pharmaceuticals Insider Trading History
SEC Filings (Institutional Ownership Changes) for PMV Pharmaceuticals (NASDAQ:PMVP)
90.20% of PMV Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.
Institutional Buying and Selling by Quarter
This chart shows the instiutional buying and selling at PMVP by year and by quarter.
Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
PMV Pharmaceuticals Institutional Trading History
Data available starting January 2016
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.
Read More on PMV Pharmaceuticals
Volume
41,035 shs
Average Volume
139,078 shs
Market Capitalization
$64.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.45
Who are the company insiders with the largest holdings of PMV Pharmaceuticals?
Who are the major institutional investors of PMV Pharmaceuticals?
Which major investors are selling PMV Pharmaceuticals stock?
Within the previous quarter, PMVP stock was sold by these institutional investors:
- Assenagon Asset Management S.A.
- Jacobs Levy Equity Management Inc.
- ArrowMark Colorado Holdings LLC
- Bank of America Corp DE
- Connor Clark & Lunn Investment Management Ltd.
- Millennium Management LLC
- Two Sigma Advisers LP
- Schonfeld Strategic Advisors LLC
Within the last year, company insiders that have sold PMV Pharmaceuticals company stock include:
- Deepika Jalota (Insider)
- Michael Carulli (CFO)
Learn More investors selling PMV Pharmaceuticals stock.
Which major investors are buying PMV Pharmaceuticals stock?
In the previous quarter, PMVP stock was purchased by institutional investors including:
- BML Capital Management LLC
- Stonepine Capital Management LLC
- Peapod Lane Capital LLC
- Aldebaran Capital LLC
- Bridgeway Capital Management LLC
- Velan Capital Investment Management LP
- Squarepoint Ops LLC
- Two Sigma Investments LP